This call is for translational research seeking to find a cure, or improved treatments and tests for cancer – advancing the work already done at a fundamental stage in order to move this towards patient application. We define this using the derived term “from bench to bedside”.
Translational research is the process whereby ideas and discoveries from emerging research projects are translated into products of therapeutic value for human patient benefit. Where discoveries in “basic science” improve our understanding of a disease, the aim of translational research is to move basic science into practice and to improve human health through the development of drugs, therapies, techniques and medical devices.
Applications may consider:
Applications for this funding round are open to researchers across the United Kingdom. In making their applications, researchers should consider the relevance of their application to the people of the North West of England and North Wales. This could mean overall incidence or that the particular cancer type if more common or associated with poor outcomes within the region.
Applicants may be from academic, healthcare, social care or other sectors. We encourage collaborations between institutions and NHS organisations and encourage collaborative applications within our regional footprint.
The Translational Research call accepts grant proposals of up to three years, with funding of up to £275,000. Researchers should be mindful of the current resources available to NWCR. All applications will be equally considered, regardless of whether funding is requested at the higher or lower end of the funding budget.
All applications will undergo rigorous external peer and scientific review. Panel members can be viewed here.
This funding round will close at 5pm on 11th October 2021.
Applications must be submitted in line with call guidance and appendix A if required.
